Earnings Ahead

DXCM - DexCom, Inc.

123.5 -1.12 -0.9

DexCom, Inc.

DexCom, Inc.

About

Profile

Founded in 1999, Dexcom, Inc. is the leader in transforming diabetes care and management by providing continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes. Since our inception, we have focused


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

DXCM



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • DexCom stock soars +14% after hours on raised revenue guidance, $500M share buyback
  • DexCom Non-GAAP EPS of $0.50 beats by $0.17, revenue of $975M beats by $37.38M
  • DexCom Q3 2023 Earnings Preview
  • Boston Sci, Stryker, Dexcom, Shockwave are BoA's top medtech picks
  • Diabetes device stocks gain after Abbott CEO downplays GLP-1 threat
  • Hennessy Funds is bullish on stocks - these in particular
  • Piper sees GLP-1 drugs having limited impact on diabetes device market
  • Most crowded longs and shorts going into earnings season
  • FDA forms advisory committee to regulate digital health
  • Best Buy to sell DexCom continuous glucose monitors
  • Citi turns cautious on pharmaceuticals and biotech
  • DexCom, Tandem Diabetes fall on Apple glucose monitor new team lead
  • Insulet, Tandem Diabetes drop as weight loss drugs impact insulin use
  • DexCom cites rising glucose monitor use amid weight loss therapy
  • Dexcom G6 strengthens position as world’s most connected CGM system with a new aid offering in Germany
  • JPMorgan says time to buy MedTech based on past
  • DexCom boosts 2023 revenue guidance on Q2 results
  • DexCom Non-GAAP EPS of $0.34 beats by $0.11, revenue of $871.3M beats by $30.35M
  • DexCom Q2 2023 Earnings Preview
  • Goldman Sachs sees rays of hope in underperforming health sector
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
February 10, 2022 0.68 / 0.8819 698.2M / 697.47M Beat!
October 28, 2021 0.89 / 0.6494 650.2M / 618.65M Beat!
July 29, 2021 0.76 / 0.4439 595.1M / 551.67M Beat!
April 30, 2021 0.33 / 0.3078 505M / 486.59M Beat!
February 11, 2021 0.91 / 0.9283 568.9M / 553.01M Beat!
October 27, 2020 0.94 / 0.6409 500.9M / 500.9M Beat!
July 28, 2020 0.79 / 0.34 451.8M / 416.62M Beat!
April 29, 2020 - / 0.11 - / 354.39M
February 20, 2020 - / 0.72 - / 432.35M
November 6, 2019 0.65 / 0.2 396.3M / 347.89M Beat!
July 31, 2019 0.08 / 0.01 336.4M / 306.44M Beat!
May 1, 2019 -0.05 / -0.15 280.5M / 247.99M Beat!
February 21, 2019 0.54 / 0.17 338M / 308.76M Beat!
November 6, 2018 0.17 / -0.09 266.7M / 242.72M Beat!
August 1, 2018 -0.1 / -0.18 242.5M / 205.8M Beat!
May 2, 2018 -0.32 / -0.32 184.4M / 172.66M Beat!
Date Price Open High Low Vol Change ER
Oct 9, 2023 83.09 82.49
83.32
80.82
3.2M -0.16%
Oct 6, 2023 83.22 82.55
83.69
81.07
6.8M -0.93%
Oct 5, 2023 84 88.1
88.1
80.8
8.7M -4.22%
Oct 4, 2023 87.7 91.16
91.39
85.54
5.8M -3.56%
Oct 3, 2023 90.94 93.67
94.36
90.24
3.0M -3.82%
 
Oct 2, 2023 94.55 92.86
96.18
91.8
3.2M 1.34%
Sep 29, 2023 93.3 97.37
97.58
93.13
5.4M -2.26%
Sep 28, 2023 95.46 92.09
96.17
91.63
7.1M 3.66%
Sep 27, 2023 92.09 89.56
92.94
89.56
6.7M 3.92%
Sep 26, 2023 88.62 85.62
88.74
85.34
4.8M 2.97%
Sep 25, 2023 86.06 87.13
87.22
85.31
3.6M -1.65%
Sep 22, 2023 87.5 88.4
89
87.14
4.6M -1.77%
Sep 21, 2023 89.08 92.34
92.38
88.85
5.3M -3.83%
Sep 20, 2023 92.63 95.37
95.81
92.36
3.1M -1.62%
Sep 19, 2023 94.16 95.29
95.31
92.77
3.6M -1.19%
Sep 18, 2023 95.29 95.69
96.64
94.85
3.2M -1.1%
Sep 15, 2023 96.35 101.85
102.33
95.86
9.1M -5.12%
Sep 14, 2023 101.55 106.23
106.6
100.93
6.4M -3.49%
Sep 13, 2023 105.22 104.99
106.96
104.78
3.0M 0.34%
Sep 12, 2023 104.86 106.56
107.34
103.4
4.4M -2.26%
Sep 11, 2023 107.29 104.35
108.09
103.95
3.4M 2.82%
Sep 8, 2023 104.35 104.92
107.14
104.18
3.6M -0.53%
Sep 7, 2023 104.91 106.75
107.59
100.76
5.2M -1.84%
Sep 6, 2023 106.88 105.45
108.28
104.22
6.6M 6.53%
Sep 5, 2023 100.33 101.94
102.97
99.93
3.2M -1.53%
Sep 1, 2023 101.89 102.32
102.69
100.51
2.5M 0.90%
Aug 31, 2023 100.98 103.53
105.06
100.9
3.7M -2.36%
Aug 30, 2023 103.42 101.03
106.95
100.75
5.8M 2.82%
Aug 29, 2023 100.58 99.3
101.65
98.02
7.6M 1.30%
Aug 28, 2023 99.29 102.07
103.29
98.75
4.1M -1.46%
Aug 25, 2023 100.76 100.92
102.11
99.01
4.4M -0.22%
Aug 24, 2023 100.98 104.99
105.01
100.78
4.6M -3.26%
Aug 23, 2023 104.38 107.15
107.68
103.99
3.8M -2.43%
Aug 22, 2023 106.98 104.38
107.46
104.14
3.2M 2.20%
Aug 21, 2023 104.68 106
106.5
104.45
3.4M -1.29%
Aug 18, 2023 106.05 107.41
107.79
105.75
3.7M -1.63%
Aug 17, 2023 107.81 111.1
111.5
107.63
4.0M -3.01%
Aug 16, 2023 111.16 114.84
115.42
110.99
2.8M -2.93%
Aug 15, 2023 114.51 115
117.25
114.26
2.6M -1.08%
Aug 14, 2023 115.76 111.82
116.01
111.54
3.1M 3.64%
Aug 11, 2023 111.69 112.35
112.7
110.55
3.3M -1.39%
Aug 10, 2023 113.27 112.25
115.94
112.15
3.4M 2.08%
Aug 9, 2023 110.96 110.71
114.66
109.8
4.5M 0.70%
Aug 8, 2023 110.19 120.3
120.3
107.07
8.9M -8.91%
Aug 7, 2023 120.97 121
122.1
120.14
1.7M 0.53%
Aug 4, 2023 120.33 122.14
122.83
119.89
2.2M -1.43%
Aug 3, 2023 122.07 123.8
124.88
120.6
2.0M -1.41%
Aug 2, 2023 123.81 120.83
124.25
120.46
3.3M 1.48%
Aug 1, 2023 122 124.45
125.95
121.85
4.0M -2.06%
Jul 31, 2023 124.56 133.14
133.4
124.03
5.6M -5.91%
Jul 28, 2023 132.38 134.4
139.55
132.1
5.0M 2.33%
Jul 27, 2023 129.36 131.11
131.49
128.77
3.4M -1.02%
Jul 26, 2023 130.69 129.2
131.26
129.09
1.7M 0.56%
Jul 25, 2023 129.96 126.9
131.11
126.81
2.0M 1.75%
Jul 24, 2023 127.72 130.58
131.74
127.44
2.9M -2.21%
Jul 21, 2023 130.6 130.98
132.57
130.06
7.3M -0.04%
Jul 20, 2023 130.65 134.06
134.35
130.42
3.3M -2.23%
Jul 19, 2023 133.63 137.34
138.92
131.88
3.0M -3.12%
Jul 18, 2023 137.93 137.07
138.17
135.51
2.1M 0.35%
Jul 17, 2023 137.45 136.7
138.4
136.37
2.3M 0%